Jim is an innovative Life Sciences Professional with broad technical, scientific and market knowledge and track record in organisational leadership, leading through start up, acquisitions, merger and divestment of operations. Jim has specialist expertise in technology assessment, and product development processes. He is an effective team builder and project manager, having managed local, multi-site, joint venture and international alliances.

Dr. Will Shu is the Chief Scientific Officer of Accufluidics. His PhD in Nanotechnology from University of Cambridge. Currently, he is also the group leader of Biomedical Microengineering Group and Reader in microengineering at Heriot-Watt University. He is an expert in microfluidics, biosensors and nanotechnology, and has led and successfully completed over £2M research projects and contracts related to microfluidics and medical diagnostics.